Cold War II?

The scramble is on to be first with a Covid-19 vaccine. About whether the vaccine works or not, the unspoken attitude may be: Who cares? What matters is being first.

News blues…

According to a British spy agency monitoring international fiber optic cables, Russia, China, and Iran are especially competitive in targeting “vaccine research networks in the United States, Canada and Britain.”
The New York Times reports, 

Chinese intelligence hackers were intent on stealing coronavirus vaccine data, so they looked for what they believed would be an easy target. Instead of simply going after pharmaceutical companies, they conducted digital reconnaissance on the University of North Carolina and other schools doing cutting-edge research.
In short, every major spy service around the globe is trying to find out what everyone else is up to.
The coronavirus pandemic has prompted one of the fastest peacetime mission shifts in recent times for the world’s intelligence agencies, pitting them against one another in a new grand game of spy versus spy, according to interviews with current and former intelligence officials and others tracking the espionage efforts.
Nearly all of the United States’ adversaries intensified their attempts to steal American research while Washington, in turn, has moved to protect the universities and corporations doing the most advanced work. NATO intelligence, normally concerned with the movement of Russian tanks and terrorist cells, has expanded to scrutinize Kremlin efforts to steal vaccine research as well, according to a Western official briefed on the intelligence.

Last month, the world heard from Russia…

that its vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval. This raised concerns among Western scientists over a lack of safety data, with some warning that moving too quickly on a vaccine could be dangerous.
Russia denounced criticism as an attempt to undermine Moscow's research.
In a Lancet study, Russian researchers reported on two small trials, each involving 38 healthy adults aged between 18 and 60, who were given a two-part immunisation. … The report said the data showed that the vaccine was "safe, well tolerated, and does not cause serious adverse events in healthy adult volunteers".
The trials were open label and not randomised, meaning there was no placebo and the participants knew they were receiving the vaccine and were not randomly assigned to different treatment groups.

Working Russians – eligible for the test vaccine - appear skeptical.

Yuri Varlamov, a teacher in Moscow and a member of the union, said he doesn't want to take the vaccine because he doesn't believe it is safe right now.
"Before the end of trials, they cannot make it mandatory. But I know that in some schools and state bodies, people are talking about mandatory status of this vaccine by the end of this year."
Marina Balouyeva, co-chairman of the "Uchitel" union, said a petition against compulsory vaccination for teachers was more of a precaution. She is wary of Sputnik-V for several reasons. "Firstly, it is generally known that the quality of domestic vaccines is worse than that of foreign ones."
"Secondly, the vaccine was created at railway speed, which already raises concerns. It was created in haste."
Despite promises from authorities that taking the vaccine will be voluntary, she said she fears things could go differently in reality, as often happens in Russian state institutions.

Moreover, vice presidential candidate Senator Kamala Harris of California, said she would not trust President Trump’s assurances that a coronavirus vaccine was safe, that she’d not take Trump’s

“word for [its safety]. He wants us to inject bleach,” she added, referring to remarks in April when the president incomprehensibly suggested a dangerous coronavirus treatment.
Ms. Harris’s remarks came after federal officials alerted state and major city public health agencies last week to prepare to distribute a vaccine to health care workers and other high-risk groups as soon as late October or early November. Given that no vaccine candidates have completed the kind of large-scale human trials that can prove efficacy and safety, that time frame has heightened concerns that the Trump administration is seeking to rush a vaccine rollout ahead of Election Day on Nov. 3.

So, Russia, China, Iran … and Donald Trump.

Meanwhile, back at the ranch…

Today, I meet with a real estate agent to view a couple of “appropriately sized” future homes for people like me. Practical. Not romantic.